Clinical experience with omalizumab in patients with severe asthma. Real-world data

Simple item page
AudienciaPúblico en generales_ES
CoberturaMéxicoes_ES
Fecha de ingreso2026-10-05T16:34:22Z
Fecha de publicación2016-01-01
ResumenBackground: Omalizumab is a monoclonal antibody that is prescribed in a stepwise addition regimen for the treatment of severe asthma. Objectives: To report the experience of patients with severe asthma who were given omalizumab in accordance with international guides, in a context of real-world data. Methods: Open, analytical, cross-sectional, retrospective, observational clinical study with real-world data. GINA 2006 Asthma Control Scheme was used to evaluate patients, and a questionnaire was used to evaluate patient characteristics, effectiveness, safety, and tolerance to omalizumab. Results: 48 patients were studied, 34 women and 14 men with an average age of 39 years. The average disease duration was 26 years. Average serum IgE was 522 IU. At the beginning of treatment, all patients had uncontrolled asthma; at the end, 69% asthma control was obtained, 19% was partially controlled and 12% unchanged. The changes were observed at seven months on average. Conclusion: Omalizumab is effective and safe for treating severe asthma when applied in accordance with international guidelines for the management of bronchial asthma.es_ES
Doihttps://doi.org/10.29262/ram.v63i3.144es_ES
URIhttps://riuat.uat.edu.mx/handle/123456789/6116
Idiomaeses_ES
EditorialNieto Editoreses_ES
RelaciónRevista Alergia Mexicoes_ES
URL relacionadohttps://doi.org/10.29262/ram.v63i3.144es_ES
DerechosAcceso abierto (Metadatos de producción científica)es_ES
Licenciahttp://purl.org/coar/access_right/c_abf2es_ES
FuenteRevista Alergia Mexico
Palabra claveAsthmaes_ES
Palabra claveManagement stepwisees_ES
Palabra claveOmalizumabes_ES
Palabra claveReal world dataes_ES
TítuloClinical experience with omalizumab in patients with severe asthma. Real-world dataes_ES
Título alternativoExperiencia clínica con omalizumab en pacientes con asma severa. Datos del mundo reales_ES
TipoArtículoes_ES
ArbitradoHa sido Arbitradoes_ES
AutorVargas-Correa, Jorge Bernardo
AutorBracamonte-Peraza, Raúl
AutorEspinosa-Morales, Sylvia Marcela
AutorVázquez-Nava, Francisco
AutorVargas-Correa, Jorge Bernardoes_ES
AutorBracamonte-Peraza, Raúles_ES
AutorEspinosa-Morales, Sylvia Marcelaes_ES
AutorVázquez-Nava, Franciscoes_ES
InstituciónUniversidad Autónoma de Tamaulipas
InstituciónUniversidad Autónoma de Tamaulipases_ES
Número3es_ES
Rango de páginas216-226es_ES
URL relacionadahttps://doi.org/10.29262/ram.v63i3.144
Tipo de artículoIndexado
Tipo de artículoIndexadoes_ES
Volumen63es_ES

Files

Collections

Documentación Cientifica